The Effects of Sodium Butyrate, an Inhibitor of Histone Deacetylase, on the Cocaine- and Sucrose-maintained Self-administration in Rats
Overview
Authors
Affiliations
In order to substantiate the concept that cocaine behavioral effects may be influenced by histone modification, rats were trained to self-administer cocaine intravenously (0.75 mg/(kginjection)), and were systemically pretreated with sodium butyrate (NaBu), a potent histone deacetylase inhibitor, before the test session during the maintenance phase. The effect of NaBu on a control reinforcer (sucrose)-induced self-administration was also assessed. NaBu (100-200 mg/kg) was inactive in altering the cocaine (0.75 mg/(kg injection))-maintained responding and at the highest dose (400 mg/kg) it did increase cocaine-induced lever presses during the maintenance phase. On the other hand, sucrose-reinforcing potential was not altered when NaBu was given at the highest dose (400 mg/kg). These findings extend previous observations that changes in histone acetylation are relevant to cocaine-induced behavioral effects. Given that histone acetylase inhibitor enhances cocaine-induced behavioral plasticity, the therapeutic benefits of histone acetyltransferase inhibitors warrant further investigation in the experimental models of cocaine abuse.
How life events may confer vulnerability to addiction: the role of epigenetics.
Liu S, Harris A, Gewirtz J Front Mol Neurosci. 2024; 17:1462769.
PMID: 39359689 PMC: 11446245. DOI: 10.3389/fnmol.2024.1462769.
Nohesara S, Mostafavi Abdolmaleky H, Thiagalingam S Brain Sci. 2024; 14(8).
PMID: 39199463 PMC: 11352452. DOI: 10.3390/brainsci14080769.
Martella N, Pensabene D, Varone M, Colardo M, Petraroia M, Sergio W Biomedicines. 2023; 11(3).
PMID: 36979729 PMC: 10045827. DOI: 10.3390/biomedicines11030750.
Epigenetic Effects of Addictive Drugs in the Nucleus Accumbens.
Anderson E, Taniguchi M Front Mol Neurosci. 2022; 15:828055.
PMID: 35813068 PMC: 9260254. DOI: 10.3389/fnmol.2022.828055.
Drug addiction: from bench to bedside.
Cheron J, de Kerchove dExaerde A Transl Psychiatry. 2021; 11(1):424.
PMID: 34385417 PMC: 8361217. DOI: 10.1038/s41398-021-01542-0.